These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7047291)

  • 1. The pharmacology of sulpiride--a dopamine receptor antagonist.
    O'Connor SE; Brown RA
    Gen Pharmacol; 1982; 13(3):185-93. PubMed ID: 7047291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride: assessment of a pharmacologically and chemically distinct neuroleptic.
    Rich TD
    Med Hypotheses; 1984 May; 14(1):69-81. PubMed ID: 6146915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in man.
    Benfenati F; Bernardi P; Cortelli P; Capelli M; Adani C; Calzà L; Agnati LF
    Neurosci Lett; 1981 Nov; 26(3):289-95. PubMed ID: 7033836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor blocking activity of sulpiride in the canine exocrine pancreas.
    Satoh Y; Satoh H; Honda F
    Jpn J Pharmacol; 1980 Oct; 30(5):689-99. PubMed ID: 7206375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.
    Alander T; Andén NE; Grabowska-Andén M
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):145-50. PubMed ID: 7402361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M; Battaini F; Spano PF; Trabucchi M
    Acta Psychiatr Scand; 1981 Apr; 63(4):314-24. PubMed ID: 7315480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stereospecificity of hypothalamo-hypophysial dopamine receptors involved in the control of prolactin secretion in normal man: effects of sulpiride stereoisomers].
    Benfenati F; De Camillis E; Cortelli P; Orlandi F
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1226-32. PubMed ID: 7459063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulpiride isomers on the control of anterior pituitary secretion in normal man.
    Agnati LF; Cortelli P; De Camillis E; Benfenati F; Orlandi F; Fresia P
    Neurosci Lett; 1979 Dec; 15(2-3):289-94. PubMed ID: 530534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride on saline acceptance-rejection in water-deprived rats.
    Gilbert DB; Cooper SJ
    Pharmacol Biochem Behav; 1987 Apr; 26(4):687-91. PubMed ID: 3299396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
    Friedman DJ; Budai D; Krause DN; Duckles SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):853-9. PubMed ID: 2674420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mode of action of sulpiride as an atypical antidepressant agent.
    Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1982; 32():85-103. PubMed ID: 7046370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor-mediated mechanisms involved in the expression of learned activity of primate striatal neurons.
    Watanabe K; Kimura M
    J Neurophysiol; 1998 May; 79(5):2568-80. PubMed ID: 9582229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.
    Van den Buuse M; Jones CR; Wagner J
    Brain Res Bull; 1992 Feb; 28(2):289-97. PubMed ID: 1375862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats.
    Hauber W; Neuscheler P; Nagel J; Müller CE
    Eur J Neurosci; 2001 Oct; 14(8):1287-93. PubMed ID: 11703457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists.
    Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Jul; 115(3):419-29. PubMed ID: 7871084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.